Lillian Banks, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 700 University City Blvd, Blacksburg, VA 24060 Phone: 540-961-8300 Fax: 540-961-8465 |
News Archive
The research community and pharmaceutical industry have had a long-standing interest in developing peptide-based therapeutics owing to their high target specificity, potent activity, and small size relative to protein-based biologics.
Virginia's attorney general has hopes to bypass an initial appellate court review and take his state's case against the health overhaul directly to the Supreme Court. The federal Department of Justice has made clear it will oppose this request. Meanwhile, the lawsuits against the health law are just one of many paths being followed by activists who hope to undo the measure.
Immutep S.A., the biopharmaceutical company specializing in immuno-oncology, and Eddingpharm have started production of Immutep's ImmuFact IMP321 (a LAG-3Ig fusion protein) at WuXi AppTec facilities in China. The product is being produced to European, U.S. and Chinese GMP standards.
Every cell in the body, whether skin or muscle or brain, starts out as a generic cell that acquires its unique characteristics after undergoing a process of specialization. Nowhere is this process more dramatic than it is in red blood cells.
ReCor Medical, an emerging medical device company, announced today that it has completed enrollment in the REDUCE 15-patient pilot clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.
› Verified 6 days ago